On the contrary, no significant association betwwen FASL-844 polymorphisms and development of leukaemia (Chen et al., 2015), breast cancer (Sun et al., 2004a), and chronic myeloproliferative disorder (Ozdemirkiran et al., 2017) have been reported. Here, FASLG is linked to leukemia.